Stuart Arbuckle
Chief Operating Officer en VERTEX PHARMACEUTICALS INCORPORATED .
Fortuna: 21 M $ al 31/03/2024
Perfil
El Sr. Stuart A. Arbuckle es director independiente de Rhythm Pharmaceuticals, Inc., director independiente de ImmunoGen, Inc. y director de operaciones y vicepresidente ejecutivo de Vertex Pharmaceuticals, Inc. Forma parte del Consejo de Administración de Rhythm Pharmaceuticals, Inc., ImmunoGen, Inc., Biotechnology Innovation Organization y Cancer Support Community. Anteriormente, el Sr. Arbuckle fue vicepresidente y director general de la unidad de negocio de oncología de Amgen, Inc. y director de GlaxoSmithKline Plc. También formó parte del consejo de administración de Cerulean Pharma, Inc. y de Wellness Community. Se licenció en la Universidad de Leeds.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
26/02/2024 | 49 831 ( 0.02% ) | 21 M $ | 31/03/2024 |
Cargos activos de Stuart Arbuckle
Empresas | Cargo | Inicio |
---|---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Chief Operating Officer | 01/02/2021 |
RHYTHM PHARMACEUTICALS, INC. | Director/Board Member | 24/07/2019 |
Cancer Support Community
Cancer Support Community Miscellaneous Commercial ServicesCommercial Services Cancer Support Community is an American company that provides support to people with cancer. The non-profit company is based in Washington. The company focuses on helping those who experience cancer cachexia, a syndrome that causes drastic weight and muscle loss in cancer patients. The company was founded in 1982 by Harold Benjamin. Debbie Weir has been the CEO of the company since 2022. | Director/Board Member | - |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - |
Antiguos cargos conocidos de Stuart Arbuckle.
Empresas | Cargo | Fin |
---|---|---|
IMMUNOGEN, INC. | Director/Board Member | 12/02/2024 |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Director/Board Member | 01/07/2017 |
AMGEN INC. | Corporate Officer/Principal | 01/08/2012 |
GSK PLC | Corporate Officer/Principal | - |
Wellness Community
Wellness Community Miscellaneous Commercial ServicesCommercial Services Wellness Community was an outlet for those suffering cancer to receive appropriate support. The company was founded in 1982 and was headquartered in Washington, DC. | Director/Board Member | - |
Formación de Stuart Arbuckle.
University of Leeds | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 5 |
---|---|
AMGEN INC. | Health Technology |
IMMUNOGEN, INC. | Health Technology |
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
RHYTHM PHARMACEUTICALS, INC. | Health Technology |
GSK PLC | Health Technology |
Empresas privadas | 4 |
---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Wellness Community
Wellness Community Miscellaneous Commercial ServicesCommercial Services Wellness Community was an outlet for those suffering cancer to receive appropriate support. The company was founded in 1982 and was headquartered in Washington, DC. | Commercial Services |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Health Technology |
Cancer Support Community
Cancer Support Community Miscellaneous Commercial ServicesCommercial Services Cancer Support Community is an American company that provides support to people with cancer. The non-profit company is based in Washington. The company focuses on helping those who experience cancer cachexia, a syndrome that causes drastic weight and muscle loss in cancer patients. The company was founded in 1982 by Harold Benjamin. Debbie Weir has been the CEO of the company since 2022. | Commercial Services |
- Bolsa de valores
- Insiders
- Stuart Arbuckle